Performance measure summary reports

Attachment 12_Table Shell of PM Report.pdf

Paul Coverdell National Acute Stroke Program (PCNASP) Reporting System

Performance measure summary reports

OMB: 0920-1108

Document [pdf]
Download: pdf | pdf
Paul Coverdell National Acute Stroke
Registry Quarterly Performance Measure
Report (State X & Allstate)
Data Source: 00/00/00 - 00/00/00
Centers for Disease Control and Prevention - Division for Heart Disease and
Stroke Prevention

Paul Coverdell National Acute Stroke Registry Quartely Report
Demographic and Clinical Features

State Name
(N)

Total Number of Hospitals
Total Number of Patients
Patient & Arrival Demographics
18-34
35-44
45-54
55-64
65-74
75-84
85+

Gender
Missing
Male
Female

Race/Ethnicity
Non-Hispanic White
Non-Hispanic Black
Hispanic
Other
Unknown

Arrival Mode
EMS
Advance notification by EMS
Private Auto
Transfer From Another Hospital
ND/Unknown
Stroke Types

Stroke Type
Ischemic (IS)
Intracerebral hemorrhage (ICH)
Subarachnoid hemorrhage (SAH)
Transient ischemic attack (TIA)
Stroke not otherwise specified (SNS)
No stroke
Missing
Stroke Treatment Metrics

IV alteplase
All IS Patients receiving any IV alteplase
All IS IV alteplase patients having symptomatic ICH complications
All IS IV alteplase patients having life threatening complications
Mean Door to Needle Time (hours)
Median Door to Needle Time (hours)
Mean LKW to Needle Time (hours)
Median LKW to Needle Time (hours)

TIA only & SNS only

All Coverdell All Coverdell
(N)
(%)
.
.

Age

TIA Patients who received any IV alteplase
SNS Patients who received any IV alteplase

State Name
(%)

Paul Coverdell National Acute Stroke Registry Quartely Performance Measure Results
Coverdell Performance Measures

State X

All
Coverdell

HS/SNS

STK-4: IV alteplase Given
STK-7: Dysphagia Screening
STK-1: VTE Prophylaxis
STK-2: Discharged on Antithrombotics
STK-10: Assessed for Rehabilitation
STK-8: Stroke Education
STK-9: Smoking Cessation Counseling
STK-5: Antithrombotic Therapy by Day 2
STK-6: Statin Therapy at Discharge
STK-3: Anticoagulation for Atrial Fibrillation
Door to needle time in 60 minutes
Door to needle time in 45 minutes
NIH stroke scale score

IS

TIA

X
X
X
X
X
X
X
X
X
X
X
X
x

X
X
X
X
X

X
X
X
X
X
X

Ischemic Stroke Only
STK-4: IV alteplase Given
STK-7: Dysphagia Screening
STK-1: VTE Prophylaxis
STK-2: Discharged on Antithrombotics
STK-10: Assessed for Rehabilitation
STK-8: Stroke Education
STK-9: Smoking Cessation Counseling
STK-5: Antithrombotic Therapy by Day 2
STK-6: Statin Therapy at Discharge
STK-3: Anticoagulation for Atrial Fibrillation
Door to needle (IV alteplase) time in 60
Door to needle (IV alteplase) time in 45
NIH stroke scale score

White

State X
Black
Male

Female

White

All Coverdell
Black
Male

Female

TIA Only
STK-2: Discharged on Antithrombotics
STK-8: Stroke Education
STK-9: Smoking Cessation Counseling
STK-5: Antithrombotic Therapy by Day 2
STK-6: Statin Therapy at Discharge
STK-3: Anticoagulation for Atrial Fibrillation

White

State X
Black
Male

Female

White

All Coverdell
Black
Male

Female

Hemorrhagic Stroke Only
STK-7: Dysphagia Screening
STK-1: VTE Prophylaxis
STK-10: Assessed for Rehabilitation
STK-8: Stroke Education
STK-9: Smoking Cessation Counseling

White

State X
Black
Male

Female

White

All Coverdell
Black
Male

Female

Defect Free Care

State X

All
Coverdell

Ischemic Inpatient
Ischemic Discharge
HM
TIA
Data source: 00/00/00 - 00/00/00 All are weighted estimates
Values filled in yellow imply a statistically significant disparity


File Typeapplication/pdf
File TitleAttachment_Table Shell of PM Report.xlsx
Authornre1
File Modified2020-11-06
File Created2020-11-06

© 2024 OMB.report | Privacy Policy